Research and experimental development on natural sciences and engineering
PHARMA HOLDINGS AS
Revenue 2024
NOK 120,000
Operating profit
NOK −17.8m
Equity
NOK 8.2m
Incorporated
2016
Employees
5
Share capital
NOK 1.4m
Key figures · 2024
Current ratio
2.43
Equity ratio
85.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -14827.3% | |
| Net margin (%%) | -14662.7% | |
| Return on assets (%%) | -187.3% | |
| Likviditet | ||
| Current ratio | 2.43 | |
| Working capital | 1.8m | |
| Soliditet | ||
| Equity ratio (%%) | 85.9% | |
| Debt-to-equity ratio | 0.16 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.